To validate the above model in human tumor tissues, we assessed protein expression levels of SGLT2 and PD-L1 in a cohort of 100 patients with lung cancer (Figure 8A, Supplemental Figure 7A, and Supplemental Table 2). The gene discussed is SLC5A2; the disease is lung cancer.